Co-existence of primary hyperparathyroidism and Parkinson's disease in three patients: An incidental finding?(322 views visite) De Rosa A, Rinaldi C, Tucci T, Pappata S, Rossi F, Morra VB, Faggiano A, Colao A, De Michele G
Department of Neurological Sciences, Federico II University, Via Pansini 5, 80131 Naples, Italy Biostructure and Bioimaging Institute, CNR, Department of Biomorphological and Functional Sciences, Federico II University, Naples, Italy Department of Molecular and Clinical Endocrinology, Federico II University of Naples, Naples, Italy
References Riferimenti: Jay, C.A., Abrams, G.M., Other endocrinopathies of the nervous system (2008) Neurology and General Medicine, pp. 427-440. , Churchill Livingstone, New York, M.J. Aminoff (Ed.
Vaamonde, J., Legarda, I., Jimenez-Jimenez, J., Zubieta, J.L., Obeso, J.A., Levodopa-responsive parkinsonism associated with basal ganglia calcification and primary hypoparathyroidism (1993) Mov Disord, 8, pp. 398-400
Margolin, D., Hammerstad, J., Orwoll, E., McClung, M., Calhoun, D., Intracranial calcification in hyperparathyroidism associated with gait apraxia and parkinsonism (1980) Neurology, 30, pp. 1005-1007
Hirooka, Y., Yuasa, K., Hibi, K., Ishikawa, A., Sobue, G., Naruse, T., Hyperparathyroidism associated with parkinsonism (1992) Intern Med, 31, pp. 904-907
Kovacs, C.S., Howse, D.C., Yendt, E.R., Reversible parkinsonism induced by hypercalcemia and primary hyperparathyroidism (1993) Arch Intern Med, 153, pp. 1134-1136
Adami, S., Marcocci, C., Gatti, D., Epidemiology of primary hyperparathyroidism in Europe (2002) Bone Miner Res, 17 (SUPPL. 2), pp. N18-N23
Walker, M.D., McMahon, D.J., Inabnet, W.B., Lazar, R.M., Brown, I., Vardy, S., Neuropsychological features in primary hyperparathyroidism: a prospective study (2009) J Clin Endocrinol Metab, 94, pp. 1951-1958
Bofill-Cardona, E., Kudlacek, O., Yang, Q., Ahorn, H., Freissmuth, M., Nanoff, C., Binding of calmodulin to the D2-dopamine receptor reduces receptor signaling by arresting the G protein activation switch (2000) J Biol Chem, 275, pp. 32672-32680
Mosharov, E.V., Larsen, K.E., Kanter, E., Phillips, K.A., Wilson, K., Schmitz, Y., Interplay between cytosolic dopamine, calcium, and alpha-synuclein causes selective death of substantia nigra neurons (2009) Neuron, 30, pp. 218-229
Jay, C. A., Abrams, G. M., Other endocrinopathies of the nervous system (2008) Neurology and General Medicine, pp. 427-440. , Churchill Livingstone, New York, M. J. Aminoff (Ed.
Kovacs, C. S., Howse, D. C., Yendt, E. R., Reversible parkinsonism induced by hypercalcemia and primary hyperparathyroidism (1993) Arch Intern Med, 153, pp. 1134-1136
Walker, M. D., McMahon, D. J., Inabnet, W. B., Lazar, R. M., Brown, I., Vardy, S., Neuropsychological features in primary hyperparathyroidism: a prospective study (2009) J Clin Endocrinol Metab, 94, pp. 1951-1958
Mosharov, E. V., Larsen, K. E., Kanter, E., Phillips, K. A., Wilson, K., Schmitz, Y., Interplay between cytosolic dopamine, calcium, and alpha-synuclein causes selective death of substantia nigra neurons (2009) Neuron, 30, pp. 218-229
Co-existence of primary hyperparathyroidism and Parkinson's disease in three patients: An incidental finding?
Not available. Non disponibile.
Co-existence of primary hyperparathyroidism and Parkinson's disease in three patients: An incidental finding?
Santulli G, Cipolletta E, Sorriento D, Del Giudice C, Anastasio A, Monaco S, Maione AS, Condorelli G, Puca A, Trimarco B, Illario M, Iaccarino G * CaMK4 gene deletion induces hypertension(284 visite) J Am Heart Assoc Journal Of The American Heart Association (ISSN: 2047-9980), 2012; 1(4): N/D-N/D. Impact Factor:2.882 DettagliEsporta in BibTeXEsporta in EndNote
Antonini A, Vitale C, Barone P, Cilia R, Righini A, Bonuccelli U, Abbruzzese G, Ramat S, Petrone A, Quatrale R, Marconi R, Ceravolo R, Stefani A, Lopiano L, Zappia M, Capus L, Morgante L, Tamma F, Tinazzi M, Colosimo C, Guerra UP, Valzania F, Fagioli G, Distefano A, Bagnato A, Feggi L, Anna S, Maria Teresa Rosaria De Cr, Nobili F, Mazzuca N, Baldari S, Eleopra R, Bestetti A, Benti R, Varrone A, Volterrani D, Massa R, Stocchi F, Schillaci O, Dore F, Zibetti M, Castellano G, Battista SG, Giorgetti G * The relationship between cerebral vascular disease and parkinsonism: The VADO study(422 visite) Parkinsonism Relat D (ISSN: 1353-8020, 1873-5126, 1873-5126electronic), 2012; 18(6): 775-780. Impact Factor:3.274 DettagliEsporta in BibTeXEsporta in EndNote
Hesse B, Tagil K, Cuocolo A, Anagnostopoulos C, Bardies M, Bax J, Bengel F, Busemann Sokole E, Davies G, Dondi M, Edenbrandt L, Franken P, Kjaer A, Knuuti J, Lassmann M, Ljungberg M, Marcassa C, Marie PY, Mckiddie F, O'connor M, Prvuolovich E, Underwood R * 3. 0 T perfusion MR imaging(551 visite) Rivista Di Neuroradiologia (ISSN: 1120-9976), 2004; 17(6): 807-812. Impact Factor:0.023 DettagliEsporta in BibTeXEsporta in EndNote
337 Records (309 escludendo Abstract e Conferenze). Impact factor totale: 1217.798 (1124.506 escludendo Abstract e Conferenze). Impact factor a 5 anni totale: 1283.916 (1173.916 escludendo Abstract e Conferenze).
Last modified by Ultima modifica di Marco Comerci on in data Sunday 12 July 2020, 13:14:58 322 views visite. Last view on Ultima visita in data Friday 26 February 2021, 9:16:09